News Potential lung cancer use for Novartis' melanoma combo New trial suggests use in lung cancer with same mutation.
ASCO-slider Eye on ASCO Day 4 - Moonshots, Money and Mobile apps You don't often get searched by the US secret service at a medical meeting.
Partner Content Partner Content The HNSCC immunotherapy race is on - and it's going to be cl... While improper to compare life saving treatments to buses - the metaphor when it comes to head and neck squamous cell carcinoma (HNSCC) is clear.
Cancer IBM Watson to aid in patient matching with cancer clinical t... Froedtert & the Medical College of Wisconsin will use IBM Watson's Clinical Trial Matching to aid patient enrolment.
Partner Content Partner Content Further Darzalex results extend hope for PFS in Myeloma Earlier this year (March), Johnson & Johnson announced that the randomized Phase III CASTOR trial (NCT02136134) achieved its primary endpoint and was stopped early as recommended by the Indepen
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.